EU Aims for Tougher Scrutiny of Silicon Valley Data-Heavy Deals

Advertisement
By Gaspard Sebag, Bloomberg | Updated: 7 October 2016 18:14 IST

The European Union may include purchase prices in the criteria used to trigger its antitrust probes, aiming to catch more data-heavy transactions in serious merger reviews in another warning shot to Silicon Valley.

The European Commission said Friday the EU's revenue-based rules mean some deals can currently avoid scrutiny when the target company doesn't have significant sales even if it "already plays a competitive role, holds commercially valuable data, or has a considerable market potential for other reasons."

EU antitrust chief Margrethe Vestager, who took office at the end of 2014, has signaled a willingness to delve more into how merging companies leverage the trove of data at their disposal. Data was one of the key considerations in the review of Facebook Inc.'s takeover of messaging service WhatsApp Inc. While the EU cleared it in October 2014, Vestager said last month officials were now "asking some follow-up questions" about privacy-policy changes.

Advertisement

Vestager signalled in June that Microsoft Corp.'s acquisition of professional social network LinkedIn Corp. is another deal where any EU probe would likely focus on its potential to leverage vast amounts of user data.

Advertisement

"Players in the digital economy may have considerable actual or potential market impact that may be reflected in high acquisition values, although they may not yet generate any or only little turnover," the EU said Friday as it sought feedback on possible changes. "It has been suggested to complement the existing turnover-based jurisdictional thresholds of the EU merger regulation by additional notification requirements based on alternative criteria, such as the transaction value."

The EU considers the possible legal gap may also affect the pharmaceutical industry.

Advertisement

"There have been indeed a number of highly valued acquisitions, by major pharmaceutical companies, of small biotechnology companies, which predominantly research and develop new treatments that may have high commercial potential, and do not yet generate any or only little turnover," the commission said.

© 2016 Bloomberg L.P.

 

For the latest tech news and reviews, follow Gadgets 360 on X, Facebook, WhatsApp, Threads and Google News. For the latest videos on gadgets and tech, subscribe to our YouTube channel. If you want to know everything about top influencers, follow our in-house Who'sThat360 on Instagram and YouTube.

Further reading: EU, Facebook, WhatsApp, Margrethe Vestager
Advertisement

Related Stories

Popular Mobile Brands
  1. Amazon Great Indian Festival Sale: Deals on Smartphones, Laptops Teased
  2. iQOO 15 Tipped to Debut With 7,000mAh Battery and This Snapdragon Chip
  3. Your Gmail Password Might Have Been Leaked: How to Secure Your Account
  4. Realme 15T With 50-Megapixel Selfie Camera Debuts in India: See Price
  5. Realme 15T 5G India Launch Today: All You Need to Know
  1. BCCI Says Crypto, Real Money Gaming Platforms Can’t Bid for Team India’s Title Sponsorship
  2. Scientists Discover Hidden Mantle Layer Beneath the Himalayas Challenging Century-Old Theory
  3. Astronomers Propose Rectangular Telescope to Hunt Earth-Like Planets
  4. Microsoft Testing Native Clipboard Sync Feature to Share Text Between Windows PCs, Android Devices
  5. Su From So OTT Release: When and Where to Watch This Kannada-Language Horror-Comedy Online
  6. Sennheiser Momentum 4 Wireless 80th Anniversary Edition Launched in India With Up to 60 Hour Battery Life
  7. Call of Duty Film Adaption Said to Be a 'Priority' at Paramount, Negotiations on to Acquire Rights
  8. Cannibal Solar Storm May Trigger Auroras as Powerful Geomagnetic Storm to Hit Earth Soon
  9. Apple's iPhone 8 Plus Listed as Vintage Product Ahead of iPhone 17 Launch, 11-Inch MacBook Air Now Obsolete
  10. Hidden Reason Behind Portugal’s Deadly Earthquakes Finally Explained
Gadgets 360 is available in
Download Our Apps
Available in Hindi
© Copyright Red Pixels Ventures Limited 2025. All rights reserved.